Edward M. MD Kaye

CIK 1522780 · CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.20M

Companies

6

Total Filings

116

Lifetime Open-Market Net

-$18.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STOK Director 110,874 $29.82 $3.31M -$8.05M 36 2026-06-05
CYTK Director 10,283 $70.15 $721.4K -$5.51M 50 2026-06-01
Avidity Biosciences, Inc. (RNAM) Delisted Director 0 $0 1 2026-02-27
RNA Director 6,692 $12.37 $82.8K $0 5 2025-06-12
SRPT President & CEO 71,229 $15.31 $1.09M -$4.77M 22 2017-08-07
Sarepta Therapeutics, Inc. (AVII) Delisted SVP & Chief Medical Officer $0 2 2012-04-25

Recent Filings · Page 5 of 12

116 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-22 STOK Sell (S) −42,350 -$653.5K EDGAR
2024-05-16 CYTK Grant (A) +5,600 $0 EDGAR
2024-03-19 STOK Mixed +24,350 -$68.0K EDGAR
2024-01-03 CYTK Grant (A) +148 $12.4K EDGAR
2023-12-05 STOK Mixed $0 EDGAR
2023-10-03 CYTK Grant (A) +448 $12.5K EDGAR
2023-09-08 STOK Exer (M) +20,000 $12.0K EDGAR
2023-07-05 CYTK Grant (A) +374 $12.5K EDGAR
2023-06-20 RNA Grant (A) $0 EDGAR
2023-05-18 CYTK Grant (A) +5,000 $0 EDGAR
Showing 4150 of 116
Page 5 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.